Maravai Lifesciences Holdings Inc Financial Flexibility Index
Maravai Lifesciences Holdings Inc financial flexibility index. Maravai Lifesciences Holdings Inc (MRVI) has a Financial Flexibility Index of 0.02x as of June 2026. Free cash flow of $4.36 Million (operating CF $3.99 Million minus capex $370.00K) represents 0% of total liabilities ($248.16 Million). See MRVI cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Maravai Lifesciences Holdings Inc (2018–2025)
Financial flexibility index of Maravai Lifesciences Holdings Inc from 2018 to 2025. Historical Financial Flexibility Index trend for Maravai Lifesciences Holdings Inc across 8 annual periods. Check MRVI cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Maravai Lifesciences Holdings Inc Financial Flexibility Index by Year (2018–2025)
Maravai Lifesciences Holdings Inc financial flexibility index by year from 2018 to 2025. Year-by-year free cash flow to debt coverage for Maravai Lifesciences Holdings Inc. For the full cash flow conversion analysis, see MRVI cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.11x | $-44.42 Million | $-57.57 Million | $397.87 Million | ▼ -229.6% |
| 2024 | 0.09x | $37.12 Million | $7.46 Million | $431.04 Million | ▼ -68.7% |
| 2023 | 0.27x | $191.78 Million | $126.22 Million | $697.57 Million | ▼ -31.5% |
| 2022 | 0.40x | $553.07 Million | $535.98 Million | $1.38 Billion | ▲ +43.8% |
| 2021 | 0.28x | $383.42 Million | $368.57 Million | $1.37 Billion | ▲ +75.5% |
| 2020 | 0.16x | $177.59 Million | $152.19 Million | $1.12 Billion | ▲ +67.1% |
| 2019 | 0.10x | $41.26 Million | $24.11 Million | $433.17 Million | ▲ +989.3% |
| 2018 | 0.01x | $3.42 Million | $-186.00K | $391.66 Million | — |